Avinger, Inc. Stock

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 03:55:44 2024-06-05 pm EDT 5-day change 1st Jan Change
2.03 USD +7.41% Intraday chart for Avinger, Inc. -1.46% -25.09%
Sales 2024 * 10.5M Sales 2025 * 13.93M Capitalization 3.22M
Net income 2024 * -16M Net income 2025 * -14M EV / Sales 2024 * 0.31 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.23 x
P/E ratio 2024 *
-0.06 x
P/E ratio 2025 *
-0.09 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+7.41%
1 week-1.46%
Current month-5.36%
1 month-47.95%
3 months-45.06%
6 months-36.76%
Current year-25.09%
More quotes
1 week
1.89
Extreme 1.89
2.43
1 month
1.89
Extreme 1.89
4.15
Current year
1.89
Extreme 1.89
5.45
1 year
1.89
Extreme 1.89
18.00
3 years
1.89
Extreme 1.89
438.00
5 years
1.89
Extreme 1.89
1 560.00
10 years
1.89
Extreme 1.89
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 07-03-07
Chief Executive Officer 61 14-12-28
Director of Finance/CFO 41 19-12-31
Members of the board TitleAgeSince
Chief Executive Officer 61 14-12-28
Chairman 81 14-11-30
Director/Board Member 72 11-02-28
More insiders
Date Price Change Volume
24-06-05 2.03 +7.41% 26,986
24-06-04 1.89 -10.85% 60,326
24-06-03 2.12 -1.17% 26,331
24-05-31 2.145 -0.23% 22,571
24-05-30 2.15 +4.36% 15,414

Delayed Quote Nasdaq, June 05, 2024 at 03:55 pm EDT

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.89 USD
Average target price
5 USD
Spread / Average Target
+164.55%
Consensus